Literature DB >> 11819256

Stage II surgical resection of hepatocellular carcinoma after TAE:a report of 38 cases.

Jian-Hua Wang, Gui Lin, Zhi-Ping Yan, Xiao-Lin Wang, Jie-Ming Cheng, Mao-Quan Li.   

Abstract

AIM:To evaluate the curative effect of stageII surgical resection of hepatocellular carcinoma after TAE.
METHODS: Thirty-eight patients with unresectable hepatocellular carcinoma were treated by transcatheter arterial embolization (TAE).When the sizes of tumors were markedly reduced after TAE, stage II surgical resections were performed.
RESULTS: Before TAE, the diameters of tumors were 12.84cm &amp; plusmn; 4.87cm (x &amp; plusmn;s), but reduced to 5.12 cm&amp; plusmn; 1.82cm (x&amp; plusmn; s) after TAE (P < 0.001). Pathologic examination of the resected specimens revealed obvious necrosis in most cases. After surgery, 26 patients were alive, with the longest survival of 96 months, twelve died and 10 had tumor recurrence.
CONCLUSION: Patients in moderate and advanced stages of hepatocellular carcinoma after TAE should be treated surgically, but the indication must be controlled strictly.

Entities:  

Year:  1998        PMID: 11819256      PMCID: PMC4688634          DOI: 10.3748/wjg.v4.i2.133

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

1.  Transcatheter arterial embolization in unresectable hepatocellular carcinoma.

Authors:  R Yamada; K Kishi; T Sonomura; M Tsuda; S Nomura; M Satoh
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Jun-Jul       Impact factor: 2.740

2.  Distribution of iodized oil within the liver after hepatic arterial injection.

Authors:  D L Miller; T J O'Leary; M Girton
Journal:  Radiology       Date:  1987-03       Impact factor: 11.105

3.  Hepatic artery embolization in 120 patients with unresectable hepatoma.

Authors:  R Yamada; M Sato; M Kawabata; H Nakatsuka; K Nakamura; S Takashima
Journal:  Radiology       Date:  1983-08       Impact factor: 11.105

4.  Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.

Authors:  H Ohishi; H Uchida; H Yoshimura; S Ohue; J Ueda; M Katsuragi; N Matsuo; Y Hosogi
Journal:  Radiology       Date:  1985-01       Impact factor: 11.105

5.  Hepatocellular carcinoma and metastatic cancer detected by iodized oil.

Authors:  K Nakakuma; S Tashiro; T Hiraoka; K Ogata; K Ootsuka
Journal:  Radiology       Date:  1985-01       Impact factor: 11.105

6.  Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma.

Authors:  H Uchida; H Ohishi; N Matsuo; K Nishimine; S Ohue; Y Nishimura; M Maeda; T Yoshioka
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Jun-Jul       Impact factor: 2.740

7.  A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma.

Authors:  T Kanematsu; T Furuta; K Takenaka; T Matsumata; Y Yoshida; T Nishizaki; K Hasuo; K Sugimachi
Journal:  Hepatology       Date:  1989-07       Impact factor: 17.425

8.  [Hepatic arterial infusion chemotherapy plus embolization for unresectable liver cancer--a report on 40 patients].

Authors:  J H Wang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1992-07

9.  Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer.

Authors:  K Nakakuma; S Tashiro; T Hiraoka; K Uemura; T Konno; Y Miyauchi; I Yokoyama
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

  9 in total
  8 in total

1.  Percutaneous transsplenic embolization of esophageal and gastrio-fundal varices in 18 patients.

Authors:  G Q Gong; X L Wang; J H Wang; Z P Yan; J M Cheng; S Qian; Y Chen
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection.

Authors:  Q Wang; Z Y Lin; X L Feng
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

3.  DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line.

Authors:  Zhao-Chong Zeng; Guo-Liang Jiang; Guo-Min Wang; Zhao-You Tang; Walter J Curran; George Iliakis
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

4.  Anti-hepatoma activity of resveratrol in vitro.

Authors:  Zhong-Jie Sun; Cheng-En Pan; Hong-Shan Liu; Guo-Jun Wang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 5.  Changing patterns of traumatic bile duct injuries: a review of forty years experience.

Authors:  Zhi-Qiang Huang; Xiao-Qiang Huang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

6.  Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.

Authors:  Fu-Hua Yan; Kang-Rong Zhou; Jie-Min Cheng; Jian-Hua Wang; Zhi-Ping Yan; Reng-Rong Da; Jia Fan; Yuan Ji
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma.

Authors:  Wu Ji; Jie-Shou Li; Ling-Tang Li; Wu-Hong Liu; Kuan-Sheng Ma; Xiang-Tian Wang; Zhen-Ping He; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 8.  Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion.

Authors:  Jian-Hong Zhong; A Chapin Rodríguez; Yang Ke; Yan-Yan Wang; Lin Wang; Le-Qun Li
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.